Oak Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.15M Sell
40,265
-85
-0.2% -$6.86K 1.01% 30
2026
Q1
$3.5M Buy
40,350
+825
+2% +$79K 1.2% 23
2025
Q4
$3.8M Buy
39,525
+40
+0.1% +$3.88K 1.29% 23
2025
Q3
$3.76M Sell
39,485
-815
-2% -$74.9K 1.29% 22
2025
Q2
$3.51M Buy
40,300
+220
+0.5% +$18.7K 1.26% 23
2025
Q1
$3.6M Buy
40,080
+443
+1% +$39.6K 1.32% 21
2024
Q4
$3.17M Buy
39,637
+1,152
+3% +$99.7K 1.17% 25
2024
Q3
$3.46M Sell
38,485
-315
-0.8% -$26.5K 1.23% 26
2024
Q2
$3.05M Sell
38,800
-1,170
-3% -$95.9K 1.12% 29
2024
Q1
$3.48M Buy
39,970
+29
+0.1% +$2.48K 1.3% 25
2023
Q4
$3.29M Sell
39,941
-174
-0.4% -$13.3K 1.31% 25
2023
Q3
$3.14M Buy
40,115
+2,000
+5% +$167K 1.35% 23
2023
Q2
$3.36M Sell
38,115
-15
-0% -$1.29K 1.39% 21
2023
Q1
$3.07M Buy
38,130
+682
+2% +$55.6K 1.33% 23
2022
Q4
$2.91M Buy
37,448
+130
+0.3% +$10.5K 1.31% 25
2022
Q3
$3.01M Buy
+37,318
New +$3.35M 1.46% 20
2022
Q2
Sell
-33,917
Closed -$3.76M 123
2022
Q1
$3.76M Buy
33,917
+269
+0.8% +$28.4K 1.49% 20
2021
Q4
$3.48M Buy
33,648
+983
+3% +$114K 1.33% 28
2021
Q3
$3.94M Buy
32,665
+110
+0.3% +$14.2K 1.64% 21
2021
Q2
$4.04M Buy
32,555
+1,531
+5% +$192K 1.7% 22
2021
Q1
$3.67M Sell
31,024
-140
-0.4% -$16.4K 1.98% 21
2020
Q4
$3.65M Sell
31,164
-65
-0.2% -$7.16K 1.78% 20
2020
Q3
$3.49M Sell
31,229
-113
-0.4% -$11.3K 1.85% 18
2020
Q2
$2.87M Buy
31,342
+359
+1% +$34.4K 1.7% 20
2020
Q1
$2.79M Sell
30,983
-550
-2% -$58.5K 2.03% 12
2019
Q4
$3.58M Sell
31,533
-215
-0.7% -$23.6K 1.99% 12
2019
Q3
$3.45M Sell
31,748
-198
-0.6% -$20.7K 2.08% 12
2019
Q2
$3.23M Buy
31,946
+274
+0.9% +$25K 2.01% 13
2019
Q1
$2.88M Buy
31,672
+317
+1% +$28.4K 1.91% 14
2018
Q4
$2.85M Sell
31,355
-121
-0.4% -$11.3K 2.11% 14
2018
Q3
$3.1M Buy
31,476
+196
+0.6% +$18.1K 1.88% 18
2018
Q2
$2.68M Sell
31,280
-700
-2% -$58.5K 1.83% 20
2018
Q1
$2.56M Buy
31,980
+144
+0.5% +$11.9K 1.98% 19
2017
Q4
$2.57M Buy
+31,836
New +$2.55M 1.96% 20

Other funds holding MDT

Oak Asset Management's MDT Position: Q2 2026 in Review

Oak Asset Management reduced its Medtronic (MDT) stake by 0.21% in Q2 2026, selling an estimated $6.86K and leaving 40,265 shares worth $3.15M. The position accounts for 1.01% of the portfolio, ranked #30.

Oak Asset Management first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.04M in Q2 2021. 485 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Oak Asset Management held 40,265 shares of Medtronic worth $3.15M as of Q2 2026.
  • Oak Asset Management sold 85 Medtronic shares in Q2 2026, an estimated $6.86K.
  • Medtronic made up 1.01% of Oak Asset Management's portfolio in Q2 2026, its #30 holding.
  • Oak Asset Management first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
  • Oak Asset Management's Medtronic position peaked at $4.04M in Q2 2021.
  • 485 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Oak Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.